Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Fry

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Practitioner|June 1, 1977
Iatrogenic extrapyramidal syndrome--a cautionary taleA H Fry, A W Beard
Health Trends|July 8, 1989
Homelessness and mental illnessP W Timms, A H Fry
British Medical Journal (Clinical Research Ed.)|November 6, 1982
Photophobia in lithium intoxicationR P Caplan, A H Fry
Acta Psychiatrica Scandinavica|November 1, 1982
Immunological factors in senile dementiaJ M Kellett, J M Martin, A H Fry
The Journal of Clinical Psychiatry|March 1, 1981
Serum creatinine phosphokinase activity in psychiatric patients receiving electroconvulsive therapyP J Taylor, R J Von Witt, A H Fry
FEBS Letters|October 6, 2009
Scavenger receptor control of chromogranin A-induced microglial stress and neurotoxic cascadesClaudie Hooper, Victoria A H Fry, Ioanna G Sevastou, et al.
Journal of Neurochemistry|April 19, 2008
Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptorsFleur Pinteaux-Jones, Ioanna G Sevastou, Victoria A H Fry, et al.
Journal of Neurochemistry|February 4, 2009
Differential effects of albumin on microglia and macrophages; implications for neurodegeneration following blood-brain barrier damageClaudie Hooper, Fleur Pinteaux-Jones, Victoria A H Fry, et al.
Molecular Pharmacology|October 7, 2005
Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonistChristopher J Langmead, Victoria A H Fry, Ian T Forbes, et al.
British Journal of Pharmacology|May 6, 2008
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1C J Langmead, N E Austin, C L Branch, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Practitioner|June 1, 1977
Iatrogenic extrapyramidal syndrome--a cautionary taleA H Fry, A W Beard
Health Trends|July 8, 1989
Homelessness and mental illnessP W Timms, A H Fry
British Medical Journal (Clinical Research Ed.)|November 6, 1982
Photophobia in lithium intoxicationR P Caplan, A H Fry
Acta Psychiatrica Scandinavica|November 1, 1982
Immunological factors in senile dementiaJ M Kellett, J M Martin, A H Fry
The Journal of Clinical Psychiatry|March 1, 1981
Serum creatinine phosphokinase activity in psychiatric patients receiving electroconvulsive therapyP J Taylor, R J Von Witt, A H Fry
FEBS Letters|October 6, 2009
Scavenger receptor control of chromogranin A-induced microglial stress and neurotoxic cascadesClaudie Hooper, Victoria A H Fry, Ioanna G Sevastou, et al.
Journal of Neurochemistry|April 19, 2008
Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptorsFleur Pinteaux-Jones, Ioanna G Sevastou, Victoria A H Fry, et al.
Journal of Neurochemistry|February 4, 2009
Differential effects of albumin on microglia and macrophages; implications for neurodegeneration following blood-brain barrier damageClaudie Hooper, Fleur Pinteaux-Jones, Victoria A H Fry, et al.
Molecular Pharmacology|October 7, 2005
Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonistChristopher J Langmead, Victoria A H Fry, Ian T Forbes, et al.
British Journal of Pharmacology|May 6, 2008
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1C J Langmead, N E Austin, C L Branch, et al.
Pageof 1